Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis
Clinical trial NCT03575780 · COMPLETED
Trial details
- NCT number
- NCT03575780
- Sponsor
- Athenex, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-07
- Primary completion
- 2019-04-25
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.